Golimumab, the newest TNF-α blocker, comes of age.
Year: 2015
Type: article
Source: PubMed
Institutions: Democritus University of Thrace, University of Ioannina
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W29053593
